Expect a resolution that saves face for all
and not under the most favorable circumstances. Along with other newspapers and periodicals, The New York Times has lately put Walgreens in its cross hairs, with attention-grabbing headlines such as these:
Opinion
How retail pharmacies can play a role in the discount card market
Prescription drug discount cards are a fast-growing market. The growing complexity of insurance plans and a system of pharmaceutical discounts and rebates that is not visible to the patient have widened the discrepancy between the cost of drugs and what patients actually pay.
CVS takes another step to revamp health care
CVS Health’s long anticipated push into primary care represents yet another milestone for the company, which in little more than three decades has transformed itself from a regional drug chain into one of the nation’s leading multifaceted health care providers, as well as a potential turning point i
Drug stores should leave their past behind
Imagine, if you can, a drug store without a pharmacy. Once upon a not-so-distant time, many chain drug stores opened without pharmacies, calling themselves health and beauty aid stores.
At-home diagnostics offers ‘a lucrative opportunity’
At-home diagnostic testing has grown from a nascent pre-pandemic trend to an emerging, high-growth health product category in the pandemic’s wake. The accelerated adoption of over-the-counter COVID-19 rapid antigen tests used for at-home self-testing was the tipping point.
Amazon’s RxPass part of a bigger picture
By now it has become a familiar refrain: Amazon is taking another step to extend its reach in the $4 trillion health care sector.
Some relatively easy industry predictions
The new year has been under way for about a month now, and speculation about the upcoming 12 months already abounds. Not to be left at the starting gate, here’s a look from Chain Drug Review’s headquarters into what just might happen between now and December 31 and what will remain anyone’s guess.
Pharmacists can fill a gap in care for rare diseases
How could an economic downturn in 2023 impact the most vulnerable patients? If we look at lessons from past recessions, we see that increases in unemployment, inflation and financial stress significantly impact access to medicines.
The culture wars are coming to drug chains
including the two biggest, CVS Health and Walgreens Boots Alliance — will soon find themselves caught in the middle of the nation’s culture wars, having been thrust into the debate over abortion rights by a recent shift in policy at the
Donigan’s exit raises questions
The new year has gotten off with a stunning development, at least for those with no inside knowledge of chain drug retailing. Heyward Donigan, Rite Aid’s chief executive, announced she is leaving the company she joined three years ago.
CVS award spurs fond memories
As a former CVS executive, I took great pleasure in reading about Katie Pouliot, pharmacy manager of CVS Store 212 in Cranston, R.I. Pouliot received the 2022 Paragon Award from CVS Health.
Health Care Outlook 2023: Sandra Hanna, Neighbourhood Pharmacies
A key takeaway for our federal and provincial governments in Canada throughout the pandemic was that no matter how daunting, community pharmacy rose to the challenge and delivered.
Health Care Outlook 2023: Micah Cost, PQA
As we look toward 2023 and a sense of normalcy that has eluded us for the past few years, there are several big things on the horizon to keep an eye on in pharmacy, medication use and high-quality, value-based care.
Health Care Outlook 2023: Sheila Arquette, NASP
Specialty pharmacy continues to be dynamic, demanding and disruptive, undergoing rapid and dramatic change.
Health Care Outlook 2023: Scott Melville, CHPA
Last year I reported that the COVID-19 pandemic drove tremendous growth in demand for over-the-counter medicines for pain and fever, dietary supplements for immune support and wellness, and consumer medical devices for self-diagnosis and protection.